The frequency of acute kidney injury in patients with chronic hepatitis C virus infection treated with sofosbuvir ‐based regimens

ConclusionsAlthough the risk for AKI was lower than for patients treated with TVR/BOC‐based regimens, AKI was seen during 11% of SOF‐based regimens and was mostly reversible. Patients with ascites and patients using NSAIDs have an increased risk for AKI during SOF‐based antiviral therapy.

Source: Alimentary Pharmacology and Therapeutics - May 3, 2017 Category: Drugs & Pharmacology Authors: R. Maan, S. H. Al Marzooqi, J. S. Klair, J. Karkada, O. Cerocchi, M. Kowgier, S. M. Harrell, K. D. Rhodes, H. L. A. Janssen, J. J. Feld, A. Duarte ‐Rojo Tags: ORIGINAL ARTICLE Source Type: research